Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ELVN compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
ELVN
Enliven Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
JBIO
Jade Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ELVN
Enliven Therapeutics, Inc.
vs
JBIO
Jade Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
ELVN
with
JBIO
Uncorrelated: r 0.23 · 501D.
Shared co-movers
3
with ELVN
with JBIO
XNCR
Xencor Inc
r 0.35
r 0.29
IMNM
Immunome Inc.
r 0.33
r 0.28
SYRE
Spyre Therapeutics, Inc.
r 0.34
r 0.27
ELVN, solid
JBIO, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ELVN
Enliven Therapeutics, Inc.
Change
44.25
▼
−1.83%
· post 44.25
Mkt cap
$3.2B
JBIO
Jade Biosciences, Inc.
Change
14.07
▼
−1.19%
· post 14.07
Closed
Oct 30 '26
Mkt cap
$894.2M
vs
Compare
Closed
Oct 30 '26
ELVN
Enliven Therapeutics, Inc.
vs
JBIO
Jade Biosciences, Inc.
44.25
▼
−1.83%
post 44.25
Price
14.07
▼
−1.19%
post 14.07
$3.2B
Mkt cap
$894.2M
Change
Change
ELVN
44.25
▼
−1.83%
vs
JBIO
14.07
▼
−1.19%
Closed
Oct 30 '26